Connexin 43, a new therapeutic target for cardiovascular diseases

Pharmazie

Volumn 64, Issue 5, 2009, Pages 291-295

  Song, Yu Ning ^a   Zhang, Hao ^a   Zhao, Jun Yi ^a,b   Guo, Xiu Li ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTINEOPLASTIC AGENT; CALYCULIN A; COLEUSIN FACTOR; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; FSK 88; HEPTANOL; LIOTHYRONINE; MESORIDAZINE; NITROFEN; OKADAIC ACID; THIORIDAZINE; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CONGENITAL DIAPHRAGM HERNIA; CONGESTIVE HEART FAILURE; DRUG MECHANISM; GAP JUNCTION; GENE EXPRESSION; HEART; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEVELOPMENT; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HUMAN; HYPOPLASIA; ISCHEMIC HEART DISEASE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CONNEXIN 43; GENE EXPRESSION REGULATION; HUMANS;

EID: 70349240629     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8814     Document Type: Review

References (36)

1. Ai X, Pogwizd SM (2005) Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 96: 54-63.
2. Chou Y, Tsai CH, Ueng KC, Tian TY, Chen SC, Yeh HI (2007) Endothelial gap junctions are down-regulated by arsenic trioxide. Eur J Pharmacol 569: 29-36.
3. Danesh-Meyer HV, Green CR (2008) Focus on molecules: connexin 43-Mind the gap. Exp Eye Res 6. [Epub ahead of print].
4. Despantez T, Dupont E, Severs NJ, Weingart R (2007) Gap junction channels and cardiac impulse propagation. J Membrane Biol 218: 13-28.
5. Eckardt D, Kirchhoff S, Kim JS, Degen J, Theis M, Ott T et al. (2006) Cardiomyocyte-restricted deletion of connexin 43 during mouse development. J Mol Cell Cardiol 41: 963-971.
6. Geng S, Sun B, Liu S, Wang J (2007) Up-regulation of connexin 43 and gap junctional intercellular communication by Coleusin Factor is associated with growth inhibition in rat osteosarcoma UMR106 cells. Cell Biol Int 31: 1420-1427.
7. Gonzalez-Reyes S, Fernandez-Dumont V, Calonge WM, Martinez L, Tovar JA (2006) Expression of Connexin 43 in the hearts of rat embryos exposed to nitrofen and effects of vitamin A on it. Pediatr Surg Int 22: 61-65.
8. Haussing S, Schubert A, Mohr FW, Dhein S (2008) Sub-chronic nicotine exposure induces intercellular communication failure and differential down-regulation of connexins in cultured human endothelial cells. Atherosclerosis 196: 210-218.
9. Hawat G, Baroudi G (2008) Differential modulation of unapposed connexin 43 hemichannel electrical conductdance by protein kinase C isoforms. Pflügers Arch 456: 519-527.
10. Herve JC, Derangeon M, Bahbouhi B, Mesnil M, Sarrouilhe D (2007) The connexin turnover, an important modulating factor of the level of cell-tocell junctional communication: comparison with other integral membrane proteins. J Membr Biol 217: 21-33.
11. Heusch G, Büchert A, Feldhaus S, Schulz R (2006) No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 101: 354-356.
12. Howarth FC, Nowotny N, Zilahi E, El Haj MA, Lei M (2007) Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart. Mol Cell Biochem 305: 145-151.
13. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E (2003) Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 242: 129-134.
14. Kanagaratnam P, Rothery S, Patel P, Severs NJ, Peters NS (2002) Relative expression of immunplocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 39: 116-123.
15. Keevil VL, Huang CL, Chau PL, Sayeed RA, Vandenberg JI (2000) The effect of heptanol on the electrical and contractile function of the isolated, perfused rabbit heart. Pflügers Arch 440: 275-282.
16. Kostin S, Rieger M, Dammer S, Hein S, Richter M, Klövekom WP, et al. (2003) Gap junction remodeling and altered connexin 43 expression in the failing human heart. Mol Cell Bochem 242: 135-144.
17. Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J (2004) Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 62: 426-436.
18. Levin M (2002) Isolation and community: a review of the role of gap-junctional communication in embryonic patterning. J Membr Biol 185:177-192.
19. Matesic DF, Abifadel DN, Garcia EL, Jann MW (2006) Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells. Cell Biol Toxicol 22: 257-268.
20. Matsushita S, Kurihara H, Watanabe M, Okada T, Sakai T, Amano A (2006) Alterations of phosphorylation state of connexin 43 during hypoxia and reoxygenation are associated with cardiac function. J Histochem Cytochem 54: 343-353.
21. Murray KT, Mace LC, Yang Z (2007) Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm 4(3 suppl): s88-90.
22. Polontchouk L, Ebelt B, Jackels M, Dhein S (2002) Chronic effects of endothelin-1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 16: 87-89.
23. Rojas Gomez DM, Schulte JS, Mohr FW, Dhein S (2008) Alpha-1-adrenoceptor subtype selective regulation of connexin 43 expression in rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 377: 77-85.
24. Ruiz-Meana M, Rodriguez-Sinovas A, Cabestrero A, Boengler K, Heusch G, Garcia-Dorado D (2008) Mitochondrial connexin 43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res 77: 325-333.
25. Saffitz JE, Hames KY, Kanno S (2007) Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol 218:65-71.
26. Salameh A, Krautblatter S, Baessler S, Karl S, Rojas Gomez D, Dhein S et al. (2008) Signal transduction and transcriptional control of cardiac connexin 43 up-regulation after alpha- 1-adrenoceptor stimulation. J Pharmacol Exp Ther 326: 315-322.
27. Sato T, Ohkusa T, Honjo H, Suzuki S, Yoshida MA, Ishiguro YS, et al. (2008) Altered expression of connein 43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster. Am J Physiol Heart Circ Physiol 294: 1164-1173.
28. Schwanke U, Li X, Schulz R, Heusch G (2003) No ischemic preconditioning in heterozygous connexin 43-deficient mice-a further in vivo study. Basic Res Cardiol 98: 181-182.
29. Severs NJ, Dupont E, Thomas N, Kaba R, Rothery S, Jain R et al. (2006) Alterations in cardiac connexin expression in cardiomyopathies. Adv Cardiol 42: 228-242.
30. Shyu KG, Chen CC, Wang BW, Kuan P (2001) Angiotensin II receptor antagonist blocks the expression of connexin 43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes. J Mol Cell Cardio 33: 691-698.
31. Tribulova N, Shneyvays V, Mamedova LK, Moshel S, Zinman T, Shainberg A et al. (2004) Enhanced connexin-43 and a-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-L-thyronine. J Mol Histol 35: 463-470.
32. Wang R, Zhang C, Ruan Y, Liu N, Wang L (2007) Changes in phosphorylation of connexin 43 in rats during acute myocardial hypoxia and effect of antiarrhythmic peptide on the phosphorylation. J Huazhong Univ Sci Technolog Med Sci 27: 241-244.
33. Yamada KA, Rogers JG, Sundset R, Steinberg TH, Saffitz JE (2003) Upregulation of connexin 45 in heart failure. J cardiovasc Electrophysiol 14: 1205-1212.
34. Yu H, Yue P, Zhang Y, Zhao W, Xing Y, Huo Y et al. (2007) Activation of cardiac M3 receptor influences connexin 43 expression. Chin Pharmacol Bull 23: 711-715.
35. Yue P, Lü YJ, Yang BF (2006) Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs. Yao Xue Xue Bao 41: 702-705.
36. Zhang Y, Yue P, Xiao J, Yu HY, Pan ZW, Lin DH et al. (2006) Integration between M3 muscarinic acetylcholine receptor and connexin 43 as antiarrhythmic targets in rat ventricular myocardium. Yao Xue Xue Bao 41:395-400.